Page last updated: 2024-11-05

thiabendazole and Benign Neoplasms

thiabendazole has been researched along with Benign Neoplasms in 6 studies

Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate

Research Excerpts

ExcerptRelevanceReference
"Thiabendazole (TBZ) is an anthelmintic drug currently studied for anticancer purposes."1.72Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ( Cabot, PJ; Esfahani, MKM; Islam, N; Izake, EL, 2022)
"D."1.32Strongyloidiasis in patients at a comprehensive cancer center in the United States. ( Husni, R; Malathum, K; Rodriguez, SJ; Rolston, KV; Safdar, A, 2004)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Lin, R1
Elf, S1
Shan, C1
Kang, HB1
Ji, Q1
Zhou, L1
Hitosugi, T1
Zhang, L1
Zhang, S1
Seo, JH1
Xie, J1
Tucker, M1
Gu, TL1
Sudderth, J1
Jiang, L1
Mitsche, M1
DeBerardinis, RJ1
Wu, S1
Li, Y1
Mao, H1
Chen, PR1
Wang, D1
Chen, GZ1
Hurwitz, SJ1
Lonial, S1
Arellano, ML1
Khoury, HJ1
Khuri, FR1
Lee, BH1
Lei, Q1
Brat, DJ1
Ye, K1
Boggon, TJ1
He, C1
Kang, S1
Fan, J1
Chen, J1
Echevarría, I1
Zafon, E1
Barrabés, S1
Martínez, MÁ1
Ramos-Gómez, S1
Ortega, N1
Manzano, BR1
Jalón, FA1
Quesada, R1
Espino, G1
Massaguer, A1
Esfahani, MKM1
Islam, N1
Cabot, PJ1
Izake, EL1
Safdar, A1
Malathum, K1
Rodriguez, SJ1
Husni, R1
Rolston, KV1
Tada, Y1
Fujitani, T1
Yano, N1
Yuzawa, K1
Nagasawa, A1
Aoki, N1
Ogata, A1
Yoneyama, M1
Aur, RJ1

Reviews

1 review available for thiabendazole and Benign Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms;

2015

Other Studies

5 other studies available for thiabendazole and Benign Neoplasms

ArticleYear
Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer.
    Journal of inorganic biochemistry, 2022, Volume: 231

    Topics: Antineoplastic Agents; Coordination Complexes; Iridium; Mitochondria; Neoplasms; Photochemotherapy;

2022
Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy.
    ACS biomaterials science & engineering, 2022, Oct-10, Volume: 8, Issue:10

    Topics: Bromides; Drug Carriers; Humans; Male; Nanoparticles; Neoplasms; Reactive Oxygen Species; Silicon Di

2022
Strongyloidiasis in patients at a comprehensive cancer center in the United States.
    Cancer, 2004, Apr-01, Volume: 100, Issue:7

    Topics: Adolescent; Adult; Aged; Antinematodal Agents; Bronchoalveolar Lavage; Child; Feces; Female; Humans;

2004
Chronic toxicity of thiabendazole (TBZ) in CD-1 mice.
    Toxicology, 2001, Dec-28, Volume: 169, Issue:3

    Topics: Administration, Oral; Animals; Animals, Outbred Strains; Blood Platelets; Body Weight; Carcinogenici

2001
Treatment of parasitic infestation in children with malignant neoplasms.
    The Journal of pediatrics, 1971, Volume: 78, Issue:1

    Topics: Ascariasis; Child; Child, Preschool; Eosinophilia; Female; Furazolidone; Giardiasis; Humans; Infant;

1971